Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

Original Article

D.R. Camidge, H.R. Kim, M.-J. Ahn, J.C.-H. Yang, J.-Y. Han, J.-S. Lee, M.J. Hochmair, J.Y.-C. Li, G.-C. Chang, K.H. Lee, C. Gridelli, A. Delmonte, R.G. Campelo, D.-W. Kim, A. Bearz, F. Griesinger, A. Morabito, E. Felip, R. Califano, S. Ghosh, A. Spira, S.N. Gettinger, M. Tiseo, N. Gupta, J. Haney, D. Kerstein, and S. Popat

N Engl J Med 2018;379:2027-2039

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
11/21/2018
Course expires: 
11/22/2020

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Sunday, November 22, 2020 - 11:59pm.